Skip to main content
Erschienen in: Heart Failure Reviews 5/2016

25.04.2016

Targeting BNIP3 in inflammation-mediated heart failure: a novel concept in heart failure therapy

verfasst von: Patrick Asare Fordjour, Lingyang Wang, Hui Gao, Lan Li, Yadong Wang, Makafui Nyagblordzro, Kojo Agyemang, Guanwei Fan

Erschienen in: Heart Failure Reviews | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Myocardial injury activates inflammatory mediators and provokes the integration of BCL-2/adenovirus E1B 19KD interacting protein 3 (BNIP3) into mitochondrial membranes. Translocation of BNIP3 to mitochondria inexorably causes mitochondrial fragmentation. Heart failure (HF) epitomizes the life-threatening phase of BNIP3-induced mitochondrial dysfunction and cardiomyocyte death. Available data suggest that inflammatory mediators play a key role in cardiac cell demise and have been implicated in the pathogenesis of HF syndrome. In the present study, we reviewed the changes in BNIP3 protein expression levels during inflammatory response and postulated its role in inflammation-mediated HF. We also identified inflammatory mediators’ response such as stimulation of TNF-α and NO as potent inducer of BNIP3. Previous studies suggest that the pro-apoptotic protein has a common regulator with IL-1β and induces IL-6-stimulated cardiac hypertrophy. These findings corroborate our contention that interventions designed to functionally modulate BNIP3 activity during inflammatory-mediated HF may prove beneficial in preventing HF. Such a revelation will open new avenue for further research to unravel a novel therapeutic strategy in HF diseases. Moreover, understanding of the relationship between BNIP3 and inflammatory mediators in HF pathologies will not only contribute to the discovery of drugs that can inhibit inflammation-mediated heart diseases, but also enhance the current knowledge on the key role BNIP3 plays during inflammation.
Literatur
2.
Zurück zum Zitat Kuzmicic J, Del Campo A, Lopez-Crisosto C, Morales PE, Pennanen C, Bravo-Sagua R et al (2011) Mitochondrial dynamics: a potential new therapeutic target for heart failure. Rev Esp Cardiol 64(10):916–923CrossRefPubMed Kuzmicic J, Del Campo A, Lopez-Crisosto C, Morales PE, Pennanen C, Bravo-Sagua R et al (2011) Mitochondrial dynamics: a potential new therapeutic target for heart failure. Rev Esp Cardiol 64(10):916–923CrossRefPubMed
3.
Zurück zum Zitat Parra V, Verdejo H, del Campo A, Pennanen C, Kuzmicic J, Iglewski M et al (2011) The complex interplay between mitochondrial dynamics and cardiac metabolism. J Bioenerg Biomembr 43(1):47–51CrossRefPubMedPubMedCentral Parra V, Verdejo H, del Campo A, Pennanen C, Kuzmicic J, Iglewski M et al (2011) The complex interplay between mitochondrial dynamics and cardiac metabolism. J Bioenerg Biomembr 43(1):47–51CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Willerson JT, Ridker PM (2004) Inflammation as a cardiovascular risk factor. Circulation 109(21 suppl 1):II-2–II-10 Willerson JT, Ridker PM (2004) Inflammation as a cardiovascular risk factor. Circulation 109(21 suppl 1):II-2–II-10
5.
Zurück zum Zitat Libby P (2006) Inflammation and cardiovascular disease mechanisms. Clin Nutr 83(2):456–460 Libby P (2006) Inflammation and cardiovascular disease mechanisms. Clin Nutr 83(2):456–460
7.
Zurück zum Zitat Oikonomou E, Tousoulis D, Siasos G, Zaromitidou M, Papavassiliou AG, Stefanadis C (2011) The role of inflammation in heart failure: new therapeutic approaches. Hellenic J Cardiol 52(1):30–40 Epub 2011/02/05 PubMed Oikonomou E, Tousoulis D, Siasos G, Zaromitidou M, Papavassiliou AG, Stefanadis C (2011) The role of inflammation in heart failure: new therapeutic approaches. Hellenic J Cardiol 52(1):30–40 Epub 2011/02/05 PubMed
8.
Zurück zum Zitat Charakida M, Halcox JPJ (2005) Tumor necrosis factor-alpha in heart failure: more questions than answers. Rev Esp Cardiol (English Version) 58(05):470–472CrossRef Charakida M, Halcox JPJ (2005) Tumor necrosis factor-alpha in heart failure: more questions than answers. Rev Esp Cardiol (English Version) 58(05):470–472CrossRef
9.
Zurück zum Zitat Yndestad A, Damas JK, Oie E, Ueland T, Gullestad L, Aukrust P (2006) Systemic inflammation in heart failure–the whys and wherefores. Heart Fail Rev 11(1):83–92 Epub 2006/07/05 CrossRefPubMed Yndestad A, Damas JK, Oie E, Ueland T, Gullestad L, Aukrust P (2006) Systemic inflammation in heart failure–the whys and wherefores. Heart Fail Rev 11(1):83–92 Epub 2006/07/05 CrossRefPubMed
10.
Zurück zum Zitat Kim JY, Kim YJ, Lee S, Park JH (2011) BNip3 is a mediator of TNF-induced necrotic cell death. Apoptosis 16(2):114–126 Epub 2010/10/22 CrossRefPubMed Kim JY, Kim YJ, Lee S, Park JH (2011) BNip3 is a mediator of TNF-induced necrotic cell death. Apoptosis 16(2):114–126 Epub 2010/10/22 CrossRefPubMed
11.
Zurück zum Zitat Ghavami S, Eshraghi M, Kadkhoda K, Mutawe MM, Maddika S, Bay GH et al (2009) Role of BNIP3 in TNF-induced cell death—TNF upregulates BNIP3 expression. Biochim Biophys Acta (BBA) Mol Cell Res 1793(3):546–560CrossRef Ghavami S, Eshraghi M, Kadkhoda K, Mutawe MM, Maddika S, Bay GH et al (2009) Role of BNIP3 in TNF-induced cell death—TNF upregulates BNIP3 expression. Biochim Biophys Acta (BBA) Mol Cell Res 1793(3):546–560CrossRef
12.
Zurück zum Zitat Ghavami S, Eshraghi M, Kadkhoda K, Mutawe MM, Maddika S, Bay GH et al (2009) Role of BNIP3 in TNF-induced cell death–TNF upregulates BNIP3 expression. Biochim Biophys Acta 1793(3):546–560 Epub 2009/03/27 CrossRefPubMed Ghavami S, Eshraghi M, Kadkhoda K, Mutawe MM, Maddika S, Bay GH et al (2009) Role of BNIP3 in TNF-induced cell death–TNF upregulates BNIP3 expression. Biochim Biophys Acta 1793(3):546–560 Epub 2009/03/27 CrossRefPubMed
13.
Zurück zum Zitat Yook YH, Kang KH, Maeng O, Kim TR, Lee JO, Kang KI et al (2004) Nitric oxide induces BNIP3 expression that causes cell death in macrophages. Biochem Biophys Res Commun 321(2):298–305 Epub 2004/09/11 CrossRefPubMed Yook YH, Kang KH, Maeng O, Kim TR, Lee JO, Kang KI et al (2004) Nitric oxide induces BNIP3 expression that causes cell death in macrophages. Biochem Biophys Res Commun 321(2):298–305 Epub 2004/09/11 CrossRefPubMed
14.
Zurück zum Zitat Diwan A, Krenz M, Syed FM, Wansapura J, Ren X, Koesters AG et al (2007) Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice. J Clin Investig 117(10):2825–2833CrossRefPubMedPubMedCentral Diwan A, Krenz M, Syed FM, Wansapura J, Ren X, Koesters AG et al (2007) Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice. J Clin Investig 117(10):2825–2833CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Burton TR, Gibson SB (2009) The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death. Cell Death Differ 16(4):515–523CrossRefPubMedPubMedCentral Burton TR, Gibson SB (2009) The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death. Cell Death Differ 16(4):515–523CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ et al (1996) Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335(16):1182–1189CrossRefPubMed Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ et al (1996) Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335(16):1182–1189CrossRefPubMed
18.
Zurück zum Zitat Narula J, Kolodgie FD, Virmani R (2000) Apoptosis and cardiomyopathy. Curr Opin Cardiol 15(3):183–188CrossRefPubMed Narula J, Kolodgie FD, Virmani R (2000) Apoptosis and cardiomyopathy. Curr Opin Cardiol 15(3):183–188CrossRefPubMed
19.
Zurück zum Zitat Hamacher-Brady A, Brady NR, Gottlieb RA, Gustafsson AB (2006) Autophagy as a protective response to Bnip3-mediated apoptotic signaling in the heart. Autophagy 2(4):307–309CrossRefPubMed Hamacher-Brady A, Brady NR, Gottlieb RA, Gustafsson AB (2006) Autophagy as a protective response to Bnip3-mediated apoptotic signaling in the heart. Autophagy 2(4):307–309CrossRefPubMed
20.
Zurück zum Zitat Galvez AS, Brunskill EW, Marreez Y, Benner BJ, Regula KM, Kirschenbaum LA et al (2006) Distinct pathways regulate proapoptotic Nix and BNip3 in cardiac stress. J Biol Chem 281(3):1442–1448CrossRefPubMed Galvez AS, Brunskill EW, Marreez Y, Benner BJ, Regula KM, Kirschenbaum LA et al (2006) Distinct pathways regulate proapoptotic Nix and BNip3 in cardiac stress. J Biol Chem 281(3):1442–1448CrossRefPubMed
21.
Zurück zum Zitat Chaanine AH, Gordon RE, Kohlbrenner E, Benard L, Jeong D, Hajjar RJ (2013) Potential role of BNIP3 in cardiac remodeling, myocardial stiffness, and endoplasmic reticulum: mitochondrial calcium homeostasis in diastolic and systolic heart failure. Circ Heart Fail 6(3):572–583CrossRefPubMedPubMedCentral Chaanine AH, Gordon RE, Kohlbrenner E, Benard L, Jeong D, Hajjar RJ (2013) Potential role of BNIP3 in cardiac remodeling, myocardial stiffness, and endoplasmic reticulum: mitochondrial calcium homeostasis in diastolic and systolic heart failure. Circ Heart Fail 6(3):572–583CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Lee Y, Kubli DA, Hanna RA, Cortez MQ, Lee HY, Miyamoto S et al (2015) Cellular redox status determines sensitivity to BNIP3-mediated cell death in cardiac myocytes. Am J Physiol Cell Physiol 25:00273 Lee Y, Kubli DA, Hanna RA, Cortez MQ, Lee HY, Miyamoto S et al (2015) Cellular redox status determines sensitivity to BNIP3-mediated cell death in cardiac myocytes. Am J Physiol Cell Physiol 25:00273
23.
Zurück zum Zitat Graham RM, Frazier DP, Thompson JW, Haliko S, Li H, Wasserlauf BJ et al (2004) A unique pathway of cardiac myocyte death caused by hypoxia–acidosis. J Exp Biol 207(18):3189–3200CrossRefPubMed Graham RM, Frazier DP, Thompson JW, Haliko S, Li H, Wasserlauf BJ et al (2004) A unique pathway of cardiac myocyte death caused by hypoxia–acidosis. J Exp Biol 207(18):3189–3200CrossRefPubMed
24.
Zurück zum Zitat Chinnadurai G, Vijayalingam S, Gibson SB (2009) BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions. Oncogene 27(S1):S114–S127 Chinnadurai G, Vijayalingam S, Gibson SB (2009) BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions. Oncogene 27(S1):S114–S127
25.
Zurück zum Zitat Zhang L, Li L, Liu H, Borowitz JL, Isom GE (2009) BNIP3 mediates cell death by different pathways following localization to endoplasmic reticulum and mitochondrion. FASEB J 23(10):3405–3414CrossRefPubMedPubMedCentral Zhang L, Li L, Liu H, Borowitz JL, Isom GE (2009) BNIP3 mediates cell death by different pathways following localization to endoplasmic reticulum and mitochondrion. FASEB J 23(10):3405–3414CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Regula KM, Ens K, Kirshenbaum LA (2002) Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes. Circ Res 91(3):226–231CrossRefPubMed Regula KM, Ens K, Kirshenbaum LA (2002) Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes. Circ Res 91(3):226–231CrossRefPubMed
27.
28.
Zurück zum Zitat Hamacher-Brady A, Brady NR, Logue SE, Sayen MR, Jinno M, Kirshenbaum LA et al (2006) Response to myocardial ischemia//reperfusion injury involves Bnip3 and autophagy. Cell Death Differ 14(1):146–157CrossRefPubMed Hamacher-Brady A, Brady NR, Logue SE, Sayen MR, Jinno M, Kirshenbaum LA et al (2006) Response to myocardial ischemia//reperfusion injury involves Bnip3 and autophagy. Cell Death Differ 14(1):146–157CrossRefPubMed
29.
Zurück zum Zitat Dorn GW 2nd (2010) Mitochondrial pruning by Nix and BNip3: an essential function for cardiac-expressed death factors. J Cardiovasc Transl Res 3(4):374–383CrossRefPubMedPubMedCentral Dorn GW 2nd (2010) Mitochondrial pruning by Nix and BNip3: an essential function for cardiac-expressed death factors. J Cardiovasc Transl Res 3(4):374–383CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Vasagiri N, Kutala VK (2014) Structure, function, and epigenetic regulation of BNIP3: a pathophysiological relevance. Mol Biol Rep 41(11):7705–7714CrossRefPubMed Vasagiri N, Kutala VK (2014) Structure, function, and epigenetic regulation of BNIP3: a pathophysiological relevance. Mol Biol Rep 41(11):7705–7714CrossRefPubMed
32.
Zurück zum Zitat Djavaheri-Mergny M, Amelotti M, Mathieu J, Besancon F, Bauvy C, Souquere S et al (2006) NF-κB activation represses tumor necrosis factor-alpha-induced autophagy. J Biol Chem 281(41):30373–30382 Epub 2006/07/22 CrossRefPubMed Djavaheri-Mergny M, Amelotti M, Mathieu J, Besancon F, Bauvy C, Souquere S et al (2006) NF-κB activation represses tumor necrosis factor-alpha-induced autophagy. J Biol Chem 281(41):30373–30382 Epub 2006/07/22 CrossRefPubMed
33.
Zurück zum Zitat Kaltschmidt B, Kaltschmidt C, Hofmann TG, Hehner SP, Droge W, Schmitz ML (2000) The pro- or anti-apoptotic function of NF-κB is determined by the nature of the apoptotic stimulus. Eur J Biochem/FEBS 267(12):3828–3835 Epub 2000/06/10 CrossRef Kaltschmidt B, Kaltschmidt C, Hofmann TG, Hehner SP, Droge W, Schmitz ML (2000) The pro- or anti-apoptotic function of NF-κB is determined by the nature of the apoptotic stimulus. Eur J Biochem/FEBS 267(12):3828–3835 Epub 2000/06/10 CrossRef
35.
Zurück zum Zitat Montaigne D, Hurt C, Neviere R (2012) Mitochondria death/survival signaling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies. Biochem Res Int 2012:951539CrossRefPubMedPubMedCentral Montaigne D, Hurt C, Neviere R (2012) Mitochondria death/survival signaling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies. Biochem Res Int 2012:951539CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Chiong M, Wang ZV, Pedrozo Z, Cao DJ, Troncoso R, Ibacache M et al (2011) Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis 22(2):130 Chiong M, Wang ZV, Pedrozo Z, Cao DJ, Troncoso R, Ibacache M et al (2011) Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis 22(2):130
38.
Zurück zum Zitat Prabhakaran K, Li L, Zhang L, Borowitz JL, Isom GE (2007) Upregulation of BNIP3 and translocation to mitochondria mediates cyanide-induced apoptosis in cortical cells. Neuroscience 150(1):159–167CrossRefPubMedPubMedCentral Prabhakaran K, Li L, Zhang L, Borowitz JL, Isom GE (2007) Upregulation of BNIP3 and translocation to mitochondria mediates cyanide-induced apoptosis in cortical cells. Neuroscience 150(1):159–167CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Chen L, Knowlton AA (2011) Mitochondrial dynamics in heart failure. Congest Heart Fail (Greenwich, Conn) 17(6):257–261CrossRef Chen L, Knowlton AA (2011) Mitochondrial dynamics in heart failure. Congest Heart Fail (Greenwich, Conn) 17(6):257–261CrossRef
41.
Zurück zum Zitat Crow MT (2002) Hypoxia, BNip3 proteins, and the mitochondrial death pathway in cardiomyocytes. Circ Res 91(3):183–185CrossRefPubMed Crow MT (2002) Hypoxia, BNip3 proteins, and the mitochondrial death pathway in cardiomyocytes. Circ Res 91(3):183–185CrossRefPubMed
42.
Zurück zum Zitat Syed F, Odley A, Hahn HS, Brunskill EW, Lynch RA, Marreez Y et al (2004) Physiological growth synergizes with pathological genes in experimental cardiomyopathy. Circ Res 95(12):1200–1206CrossRefPubMed Syed F, Odley A, Hahn HS, Brunskill EW, Lynch RA, Marreez Y et al (2004) Physiological growth synergizes with pathological genes in experimental cardiomyopathy. Circ Res 95(12):1200–1206CrossRefPubMed
43.
Zurück zum Zitat Fordjour PA, Wang Y, Shi Y, Agyemang K, Akinyi M, Zhang Q et al (2015) Possible mechanisms of C-reactive protein mediated acute myocardial infarction. Eur J Pharmacol 760:72–80 Epub 2015/04/22 CrossRefPubMed Fordjour PA, Wang Y, Shi Y, Agyemang K, Akinyi M, Zhang Q et al (2015) Possible mechanisms of C-reactive protein mediated acute myocardial infarction. Eur J Pharmacol 760:72–80 Epub 2015/04/22 CrossRefPubMed
44.
Zurück zum Zitat Muller-Werdan U, Buerke M, Ebelt H, Heinroth KM, Herklotz A, Loppnow H et al (2006) Septic cardiomyopathy—a not yet discovered cardiomyopathy? Exp Clin Cardiol 11(3):226–236PubMedPubMedCentral Muller-Werdan U, Buerke M, Ebelt H, Heinroth KM, Herklotz A, Loppnow H et al (2006) Septic cardiomyopathy—a not yet discovered cardiomyopathy? Exp Clin Cardiol 11(3):226–236PubMedPubMedCentral
45.
Zurück zum Zitat Lisman KA, Stetson SJ, Koerner MM, Farmer JA, Torre-Amione G (2002) The role of tumor necrosis factor alpha blockade in the treatment of congestive heart failure. Congest Heart Fail (Greenwich, Conn) 8(5):275–279 Epub 2002/10/09 CrossRef Lisman KA, Stetson SJ, Koerner MM, Farmer JA, Torre-Amione G (2002) The role of tumor necrosis factor alpha blockade in the treatment of congestive heart failure. Congest Heart Fail (Greenwich, Conn) 8(5):275–279 Epub 2002/10/09 CrossRef
46.
Zurück zum Zitat Cicoira M, Anker SD, Ronco C (2011) Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle. J Cachexia Sarcopenia Muscle 2(3):135–142CrossRefPubMedPubMedCentral Cicoira M, Anker SD, Ronco C (2011) Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle. J Cachexia Sarcopenia Muscle 2(3):135–142CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat Raymond RJ, Dehmer GJ, Theoharides TC, Deliargyris EN (2001) Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. Am Heart J 141(3):435–438 Epub 2001/03/07 CrossRefPubMed Raymond RJ, Dehmer GJ, Theoharides TC, Deliargyris EN (2001) Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. Am Heart J 141(3):435–438 Epub 2001/03/07 CrossRefPubMed
48.
Zurück zum Zitat Parissis JT, Nikolaou M, Farmakis D, Paraskevaidis IA, Bistola V, Venetsanou K et al (2009) Self-assessment of health status is associated with inflammatory activation and predicts long-term outcomes in chronic heart failure. Eur J Heart Fail 11(2):163–169 Epub 2009/01/27 CrossRefPubMedPubMedCentral Parissis JT, Nikolaou M, Farmakis D, Paraskevaidis IA, Bistola V, Venetsanou K et al (2009) Self-assessment of health status is associated with inflammatory activation and predicts long-term outcomes in chronic heart failure. Eur J Heart Fail 11(2):163–169 Epub 2009/01/27 CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Pepys MB, Hirschfield GM, Tennent GA, Ruth Gallimore J, Kahan MC, Bellotti V et al (2006) Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440(7088):1217–1221CrossRefPubMed Pepys MB, Hirschfield GM, Tennent GA, Ruth Gallimore J, Kahan MC, Bellotti V et al (2006) Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440(7088):1217–1221CrossRefPubMed
50.
Zurück zum Zitat Fearon WF, Fearon DT (2008) Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist. Circulation 117(20):2577–2579CrossRefPubMed Fearon WF, Fearon DT (2008) Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist. Circulation 117(20):2577–2579CrossRefPubMed
51.
Zurück zum Zitat Zhang S, Zhang Z, Sandhu G, Ma X, Yang X, Geiger JD et al (2007) Evidence of oxidative stress-induced BNIP3 expression in amyloid beta neurotoxicity. Brain Res 1138:221–230CrossRefPubMed Zhang S, Zhang Z, Sandhu G, Ma X, Yang X, Geiger JD et al (2007) Evidence of oxidative stress-induced BNIP3 expression in amyloid beta neurotoxicity. Brain Res 1138:221–230CrossRefPubMed
52.
Zurück zum Zitat Quinsay MN, Thomas RL, Lee Y, Gustafsson AB (2010) Bnip3-mediated mitochondrial autophagy is independent of the mitochondrial permeability transition pore. Autophagy 6(7):855–862CrossRefPubMedPubMedCentral Quinsay MN, Thomas RL, Lee Y, Gustafsson AB (2010) Bnip3-mediated mitochondrial autophagy is independent of the mitochondrial permeability transition pore. Autophagy 6(7):855–862CrossRefPubMedPubMedCentral
53.
Zurück zum Zitat Rikka S, Quinsay MN, Thomas RL, Kubli DA, Zhang X, Murphy AN et al (2011) Bnip3 impairs mitochondrial bioenergetics and stimulates mitochondrial turnover. Cell Death Differ 18(4):721–731CrossRefPubMed Rikka S, Quinsay MN, Thomas RL, Kubli DA, Zhang X, Murphy AN et al (2011) Bnip3 impairs mitochondrial bioenergetics and stimulates mitochondrial turnover. Cell Death Differ 18(4):721–731CrossRefPubMed
54.
Zurück zum Zitat Morin D, Assaly R, Paradis S, Berdeaux A (2009) Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection. Curr Med Chem 16(33):4382–4398CrossRefPubMedPubMedCentral Morin D, Assaly R, Paradis S, Berdeaux A (2009) Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection. Curr Med Chem 16(33):4382–4398CrossRefPubMedPubMedCentral
55.
Zurück zum Zitat Prabhakaran K, Chapman GD, Gunasekar PG (2009) BNIP3 up-regulation and mitochondrial dysfunction in manganese-induced neurotoxicity. Neurotoxicology 30(3):414–422CrossRefPubMed Prabhakaran K, Chapman GD, Gunasekar PG (2009) BNIP3 up-regulation and mitochondrial dysfunction in manganese-induced neurotoxicity. Neurotoxicology 30(3):414–422CrossRefPubMed
57.
Zurück zum Zitat Trocoli A, Djavaheri-Mergny M (2011) The complex interplay between autophagy and NF-κB signaling pathways in cancer cells. Am J Cancer Res 1(5):629–649PubMed Trocoli A, Djavaheri-Mergny M (2011) The complex interplay between autophagy and NF-κB signaling pathways in cancer cells. Am J Cancer Res 1(5):629–649PubMed
58.
Zurück zum Zitat Dorn GW (2009) Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res 81(3):465–473CrossRefPubMed Dorn GW (2009) Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res 81(3):465–473CrossRefPubMed
59.
Zurück zum Zitat Diwan A, Dorn GW (2007) Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets. Physiology (Bethesda) 22:56–64CrossRef Diwan A, Dorn GW (2007) Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets. Physiology (Bethesda) 22:56–64CrossRef
60.
Zurück zum Zitat Weng YJ, Kuo WW, Kuo CH, Tung KC, Tsai CH, Lin JA et al (2010) BNIP3 induces IL6 and calcineurin/NFAT3 hypertrophic-related pathways in H9c2 cardiomyoblast cells. Mol Cell Biochem 345(1–2):241–247 Epub 2010/09/21 CrossRefPubMed Weng YJ, Kuo WW, Kuo CH, Tung KC, Tsai CH, Lin JA et al (2010) BNIP3 induces IL6 and calcineurin/NFAT3 hypertrophic-related pathways in H9c2 cardiomyoblast cells. Mol Cell Biochem 345(1–2):241–247 Epub 2010/09/21 CrossRefPubMed
61.
Zurück zum Zitat Krenek P, Kmecova J, Kucerova D, Bajuszova Z, Musil P, Gazova A et al (2009) Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function. Eur J Heart Fail 11(2):140–146 Epub 2009/01/27 CrossRefPubMedPubMedCentral Krenek P, Kmecova J, Kucerova D, Bajuszova Z, Musil P, Gazova A et al (2009) Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function. Eur J Heart Fail 11(2):140–146 Epub 2009/01/27 CrossRefPubMedPubMedCentral
62.
Zurück zum Zitat Beg AA, Baltimore D (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274(5288):782–784CrossRefPubMed Beg AA, Baltimore D (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274(5288):782–784CrossRefPubMed
63.
Zurück zum Zitat Yurkova N, Shaw J, Blackie K, Weidman D, Jayas R, Flynn B et al (2008) The cell cycle factor E2F-1 activates Bnip3 and the intrinsic death pathway in ventricular myocytes. Circ Res 102(4):472–479CrossRefPubMed Yurkova N, Shaw J, Blackie K, Weidman D, Jayas R, Flynn B et al (2008) The cell cycle factor E2F-1 activates Bnip3 and the intrinsic death pathway in ventricular myocytes. Circ Res 102(4):472–479CrossRefPubMed
64.
Zurück zum Zitat Gang H, Dhingra R, Wang Y, Mughal W, Gordon JW, Kirshenbaum LA (2011) Epigenetic regulation of E2F-1-dependent Bnip3 transcription and cell death by nuclear factor-κB and histone deacetylase-1. Pediatr Cardiol 32(3):263–266CrossRefPubMed Gang H, Dhingra R, Wang Y, Mughal W, Gordon JW, Kirshenbaum LA (2011) Epigenetic regulation of E2F-1-dependent Bnip3 transcription and cell death by nuclear factor-κB and histone deacetylase-1. Pediatr Cardiol 32(3):263–266CrossRefPubMed
65.
Zurück zum Zitat Baetz D, Regula KM, Ens K, Shaw J, Kothari S, Yurkova N et al (2005) Nuclear factor-κB–mediated cell survival involves transcriptional silencing of the mitochondrial death gene BNIP3 in ventricular myocytes. Circulation 112(24):3777–3785CrossRefPubMed Baetz D, Regula KM, Ens K, Shaw J, Kothari S, Yurkova N et al (2005) Nuclear factor-κB–mediated cell survival involves transcriptional silencing of the mitochondrial death gene BNIP3 in ventricular myocytes. Circulation 112(24):3777–3785CrossRefPubMed
66.
Zurück zum Zitat Shaw J, Zhang T, Rzeszutek M, Yurkova N, Baetz D, Davie JR et al (2006) Transcriptional silencing of the death gene BNIP3 by cooperative action of NF-κB and histone deacetylase 1 in ventricular myocytes. Circ Res 99(12):1347–1354CrossRefPubMed Shaw J, Zhang T, Rzeszutek M, Yurkova N, Baetz D, Davie JR et al (2006) Transcriptional silencing of the death gene BNIP3 by cooperative action of NF-κB and histone deacetylase 1 in ventricular myocytes. Circ Res 99(12):1347–1354CrossRefPubMed
67.
Zurück zum Zitat Gordon JW, Shaw JA, Kirshenbaum LA (2011) Multiple facets of NF-κB in the heart: to be or not to NF-κB. Circ Res 108(9):1122–1132CrossRefPubMed Gordon JW, Shaw JA, Kirshenbaum LA (2011) Multiple facets of NF-κB in the heart: to be or not to NF-κB. Circ Res 108(9):1122–1132CrossRefPubMed
68.
Zurück zum Zitat Lakshmi SV, Naushad SM, Reddy CA, Saumya K, Rao DS, Kotamraju S et al (2013) Oxidative stress in coronary artery disease: epigenetic perspective. Mol Cell Biochem 374(1–2):203–211CrossRefPubMed Lakshmi SV, Naushad SM, Reddy CA, Saumya K, Rao DS, Kotamraju S et al (2013) Oxidative stress in coronary artery disease: epigenetic perspective. Mol Cell Biochem 374(1–2):203–211CrossRefPubMed
69.
Zurück zum Zitat Murai M, Toyota M, Satoh A, Suzuki H, Akino K, Mita H et al (2005) Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours. Br J Cancer 92(6):1165–1172CrossRefPubMedPubMedCentral Murai M, Toyota M, Satoh A, Suzuki H, Akino K, Mita H et al (2005) Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours. Br J Cancer 92(6):1165–1172CrossRefPubMedPubMedCentral
70.
Zurück zum Zitat Okami J, Simeone DM, Logsdon CD (2004) Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. Cancer Res 64(15):5338–5346CrossRefPubMed Okami J, Simeone DM, Logsdon CD (2004) Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. Cancer Res 64(15):5338–5346CrossRefPubMed
71.
Zurück zum Zitat Gheorghiade M, Sopko G, De Luca L, Velazquez EJ, Parker JD, Binkley PF et al (2006) Navigating the crossroads of coronary artery disease and heart failure. Circulation 114(11):1202–1213CrossRefPubMed Gheorghiade M, Sopko G, De Luca L, Velazquez EJ, Parker JD, Binkley PF et al (2006) Navigating the crossroads of coronary artery disease and heart failure. Circulation 114(11):1202–1213CrossRefPubMed
Metadaten
Titel
Targeting BNIP3 in inflammation-mediated heart failure: a novel concept in heart failure therapy
verfasst von
Patrick Asare Fordjour
Lingyang Wang
Hui Gao
Lan Li
Yadong Wang
Makafui Nyagblordzro
Kojo Agyemang
Guanwei Fan
Publikationsdatum
25.04.2016
Verlag
Springer US
Erschienen in
Heart Failure Reviews / Ausgabe 5/2016
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-016-9557-4

Weitere Artikel der Ausgabe 5/2016

Heart Failure Reviews 5/2016 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.